<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://the483.com/xai-sues-minnesota-nudification-law/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T10:42:29.000Z</news:publication_date>
      <news:title>xAI Sues Minnesota Over $500K-Per-Image AI Law</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/caldera-vidya-reverse-mergers-478m/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T09:55:28.000Z</news:publication_date>
      <news:title>Caldera, Vidya Raise $478M in Reverse Mergers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/utah-states-oregon-didmca-brief/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T21:32:21.000Z</news:publication_date>
      <news:title>Backs Challenge: Utah Leads 15 States vs Oregon</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/biogen-apellis-deal-slows-ma/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T21:05:47.000Z</news:publication_date>
      <news:title>Biogen Paid $41 a Share for Apellis, Now Slows M&amp;A</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/ebay-steiner-cyberstalking-settlement/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T10:10:40.000Z</news:publication_date>
      <news:title>eBay Settles With Couple It Cyberstalked in 2019</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/sec-crowdfunding-cap-20m/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T09:13:03.000Z</news:publication_date>
      <news:title>Weighs Raising SEC Crowdfunding Cap to $20M</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/minnesota-prediction-market-ban-blocked/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T22:07:08.000Z</news:publication_date>
      <news:title>Judge Blocks Minnesota&apos;s Kalshi, Polymarket Ban</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/replimune-rp1-data-not-interpretable/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T21:37:38.000Z</news:publication_date>
      <news:title>Sinks 32%: FDA Deems Replimune&apos;s Trial &apos;Not Interpretable&apos;</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/openai-model-breach-hugging-face/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T21:07:38.000Z</news:publication_date>
      <news:title>AI Broke Into Hugging Face. Who&apos;s Liable?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/hengrui-elevar-second-483-liver-cancer/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T20:43:28.225Z</news:publication_date>
      <news:title>Cited Again: Hengrui&apos;s 9-Flaw 483 Stalls Liver Drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/grubmarket-confidential-ipo-filing/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T20:39:17.000Z</news:publication_date>
      <news:title>GrubMarket Files Confidential IPO at $4.5B</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/gossamer-chiesi-seralutinib-deal/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T11:01:25.000Z</news:publication_date>
      <news:title>Chiesi Pays Gossamer $5M to Exit PAH Drug Deal</news:title>
    </news:news>
  </url>
</urlset>